4078
J. Itoh et al.
SPECIAL TOPIC
Methyl 3-[N-(4-Methoxyphenylamino)]-2,2-dimethyl-3-phenyl-
propionate (3a)
Rf = 0.3 (hexane–EtOAc, 10:1).
Methyl 3-[N-(4-Methoxyphenylamino)]-3-phenyl-2-triphenyl-
siloxypropionate (3d)
Mp 129.0–135.0 °C (MeOH); Rf = 0.3 (hexane–EtOAc, 10:1).
IR (CHCl3): 3422, 3015, 2953, 1724, 1514, 1236, 1138, 704, 665
cm–1.
IR (CHCl3): 3420, 3013, 2953, 1755, 1514, 1429, 1229, 1119, 739,
507 cm–1.
1H NMR (400 MHz, CDCl3): d = 1.16 (s, 3 H), 1.24 (s, 3 H), 3.65
(s, 3 H), 3.66 (s, 3 H), 4.45 (s, 1 H), 4.45 (s, 1 H), 6.45 (d, J = 8.8
Hz, 2 H), 6.63 (d, J = 8.8 Hz, 2 H), 7.25–7.28 (m, 5 H).
13C NMR (100 MHz, CDCl3): d = 177.1, 151.9, 141.2, 139.3, 128.3,
127.9, 127.3, 114.6, 114.6, 65.1, 55.6, 52.0, 47.1, 24.5, 20.4.
MS: m/z (%) = 313(3) [M+], 212 (82), 196 (100), 167 (30), 77 (28),
41 (55).
1H NMR (400 MHz, CDCl3): d = 7.23–7.54 (m, 20 H), 6.64–6.67
(m, 2 H, syn), 6.63–6.66 (m, 2 H, anti), 6.45–6.48 (m, 2 H, syn),
6.36–6.38 (m, 2 H, anti), 4.84 (dd, J = 8.4 Hz, 2.5 Hz, 1 H, syn),
4.84 (dd, J = 8.1 Hz, 5.6 Hz, 1 H, anti), 4.71 (d, J = 8.4 Hz, 1 H,
syn), 4.71 (d, J = 8.1 Hz, 1 H, anti), 4.66 (d, J = 5.6 Hz, 1 H, anti),
4.65 (d, J = 2.5 Hz, 1 H, syn), 3.67 (s, 3 H, syn), 3.67 (s, 3 H, anti),
3.35 (s, 3 H, syn) 3.32 (s, 3 H, anti).
13C NMR (100 MHz, CDCl3): d (syn) = 171.5, 152.0, 140.8, 138.6,
135.5, 133.1, 130.0, 128.5, 127.7, 127.4, 127.4, 114.7, 114.7, 60.9,
60.4, 55.7, 51.8.
Anal. Calcd for C19H23NO3: C, 72.82; H, 7.40; N, 4.47. Found: C,
72.71; H, 7.25; N, 4.76.
13C NMR (100 MHz, CDCl3): d (anti) = 171.1, 152.2, 140.6, 138.7,
134.9, 133.1, 130.2, 128.3, 127.9, 127.4, 127.3, 115.1, 114.7, 61.7,
60.9, 55.6, 51.5.
MS: m/z (%) = 559 (2) [M+], 271 (2), 270 (2), 256 (6), 213 (16), 212
(100), 199 (2), 197 (3), 196 (3), 183 (2), 181 (3), 180 (3), 168 (5),
134 (4), 105 (2), 77 (2).
Methyl 2-Benzyl-3-[N-(4-methoxyphenylamino)]-3-phenyl-
propionate (3b)
Mp 111.0–113.0 °C (EtOH); Rf = 0.3 (hexane–EtOAc, 10:1).
IR (CHCl3): 3416, 3013, 2835, 1720, 1510, 1454, 1236, 1180, 1038,
820, 700, 519 cm–1.
1H NMR (400 MHz, CDCl3): d = 7.08–7.40 (m, 10 H), 6.65–6.74
(m, 2 H), 6.45–6.50 (m, 2 H), 4.62 (d, J = 5.5 Hz, 1 H, anti), 4.47
(d, J = 5.3 Hz, 1 H, syn), 4.35 (s, 1 H, anti), 4.36 (s, 1 H, syn), 4.36
(br s, 1 H), 3.90 (q, J = 7.1 Hz, 2 H, anti), 3.93 (q, J = 7.1 Hz, 2 H,
syn), 3.69 (s, 3 H, anti), 3.68 (s, 3 H, syn), 3.00–3.14 (m, 2 H), 2.85–
2.96 (m, 1 H), 0.97 (t, J = 7.1 Hz, 3 H, anti), 0.95 (t, J = 7.1 Hz, 3 H,
syn).
Anal. Calcd for C35H33NO4Si: C, 75.10; H, 5.94; N, 2.50. Found: C,
74.88; H, 5.73; N, 2.48.
Methyl 3-[N-(4-Methoxyphenylamino)]-2,3-diphenyl-
propionate (3e)
Mp 145.5–147.0 °C (MeOH); Rf = 0.3 (hexane–EtOAc, 8:1).
IR (CHCl3): 3398, 3031, 2955, 2835, 1734, 1512, 1454, 1240, 1163,
1036, 822, 700, 665 cm–1.
13C NMR (100 MHz, CDCl3): d (anti) = 173.1, 152.2, 141.2, 140.7,
139.3, 128.8, 128.5, 128.4, 127.5, 127.0, 126.3, 115.0, 114.7, 60.6,
60.5, 55.7, 54.6, 33.7, 13.9.
13C NMR (100 MHz, CDCl3): d (syn) = 174.0, 151.8, 141.5, 141.0,
138.6, 128.9, 128.5, 128.4, 127.3, 126.7, 126.5, 114.7, 114.5, 60.5,
59.0, 55.7, 54.7, 36.4, 13.9.
1H NMR (400 MHz, CDCl3): d = 7.08–7.46 (m, 10 H), 6.62–6.67
(m, 2 H, syn), 6.56–6.60 (m, 2 H, anti), 6.52–6.55 (m, 2 H, syn),
6.31–6.35 (m, 2 H, anti), 4.87 (d, J = 8.6 Hz, 1 H, syn), 4.87 (d,
J = 9.9 Hz, 1 H, anti), 3.93 (d, J = 8.6 Hz, 1 H, syn), 3.87 (d, J = 9.9
Hz, 1 H, anti), 3.63 (s, 3 H, anti), 3.63 (s, 3 H, syn), 3.44 (s, 3 H,
syn), 3.44 (s, 3 H, anti).
MS: m/z (%) = 389 (6) [M+], 213 (13), 212 (100), 196 (11), 91 (12).
13C NMR (100 MHz, CDCl3): d (anti) = 171.9, 152.4, 141.7, 141.2,
135.1, 129.0, 128.8, 128.5, 128.2, 127.6, 127.3, 115.5, 114.5, 64.3,
60.0, 55.6, 51.9.
13C NMR (100 MHz, CDCl3): d (syn) = 172.9, 152.3, 140.8, 140.6,
135.5, 128.8, 128.3, 128.3, 127.5, 127.2, 127.9, 115.6, 114.6, 62.4,
58.9, 55.6, 52.2.
Anal. Calcd for C25H27NO3: C, 77.09; H, 6.99; N, 3.60. Found: C,
76.87; H, 6.71; N, 3.57.
Methyl 3-[N-(4-Methoxyphenylamino)]-2-methyl-3-phenyl-
propionate (3c)
Oil; Rf = 0.3 (hexane–EtOAc, 8:1).
IR (CHCl3): 3420, 3032, 2835, 1724, 1510, 1244, 1182, 1040, 820,
702, 521 cm–1.
MS: m/z (%) = 211 (82), 196 (100), 167 (25), 92 (11), 89 (12), 77
(20), 64 (17), 63 (18), 51 (16).
1H NMR (400 MHz, CDCl3): d = 7.19–7.32 (m, 5 H), 6.64–6.68 (m,
2 H), 6.46–6.50 (m, 2 H), 4.63 (d, J = 5.3 Hz, 1 H, syn), 4.41 (d,
J = 7.7 Hz, 1 H, anti), 4.32 (br s, 1 H), 4.11 (q, J = 7.1 Hz, 2 H, an-
ti), 4.06 (q, J = 7.1 Hz, 2 H, syn), 3.68 (s, 3 H, anti), 3.67 (s, 3 H,
syn), 2.91 (dq, J = 7.1 Hz, 5.3 Hz, 1 H, syn), 2.80 (dq, J = 7.7 Hz,
7.0 Hz, 1 H, anti), 1.16 (t, J = 7.1 Hz, 3 H, anti), 1.15 (d, J = 7.7 Hz,
3 H, syn), 1.14 (t, J = 7.1 Hz, 3 H, anti), 1.13 (d, J = 7.0 Hz, 3 H, an-
ti).
13C NMR (100 MHz, CDCl3): d (anti) = 175.0, 152.0, 141.4, 141.1,
128.5, 127.3, 126.9, 114.8, 114.7, 61.7, 60.6, 55.6, 46.9, 15.2, 14.1.
13C NMR (100 MHz, CDCl3): d (syn) = 174.3, 152.1, 141.3, 141.0,
128.4, 127.2, 126.9, 114.9, 114.7, 60.7, 60.5, 55.7, 46.2, 14.1, 11.9.
Anal. Calcd for C23H23NO3: C, 76.43; H, 6.41; N, 3.88. Found: C,
76.63; H, 6.63; N, 3.80.
Ethyl 3-[N-(4-Methoxyphenylamino)]-3-phenylpropanethioate
(3f)
Mp 76.0–77.0 °C (EtOH); Rf = 0.4 (hexane–EtOAc, 8:1).
1H NMR (400 MHz, CDCl3): d = 7.21–7.42 (m, 5 H), 6.66–6.70 (m,
2 H), 6.48–6.52 (m, 2 H), 4.76 (t, J = 6.8 Hz, 1 H), 4.27 (br s, 1 H),
3.68 (s, 3 H), 2.96 (d, J = 6.8 Hz, 2 H), 2.85 (q, J = 7.5 Hz, 2 H),
1.19 (t, J = 7.5 Hz, 3 H).
13C NMR (100 MHz, CDCl3): d = 197.3, 152.3, 142.2, 140.9, 128.7,
127.44, 126.3, 115.1, 114.7, 56.6, 55.6, 51.6, 23.6, 14.5.
MS: m/z (%) = 313 (6) [M+], 213 (15), 212 (100), 211 (16), 196 (19),
91 (6), 77 (7), 57 (8).
IR (CHCl3): 3406, 3030, 2934, 1711, 1364, 665 cm–1.
MS (DI): m/z (%) = 315 (15) [M]+, 213 (12), 212 (100), 196 (16),
Anal. Calcd for C19H23NO3: C, 72.82; H, 7.40; N, 4.47. Found: C,
72.67; H, 7.68; N, 4.67.
122 (6), 104 (5), 77 (7).
Anal. Calcd for C18H21NO2S: C, 68.54; H, 6.71; N, 4.44; S, 10.17.
Found: C, 68.82; H, 6.96; N, 4.51; S, 9.83.
Synthesis 2006, No. 23, 4075–4080 © Thieme Stuttgart · New York